| δ‐cells and β‐cells are electrically coupled and regulate α‐cell activity via somatostatin LJB Briant, TM Reinbothe, I Spiliotis, C Miranda, B Rodriguez, P Rorsman The Journal of physiology 596 (2), 197-215, 2018 | 143 | 2018 |
| Sense-antisense lncRNA pair encoded by locus 6p22. 3 determines neuroblastoma susceptibility via the USP36-CHD7-SOX9 regulatory axis T Mondal, PK Juvvuna, A Kirkeby, S Mitra, ST Kosalai, L Traxler, ... Cancer Cell 33 (3), 417-434. e7, 2018 | 135 | 2018 |
| GLP‐1 suppresses glucagon secretion in human pancreatic alpha‐cells by inhibition of P/Q‐type Ca2+ channels R Ramracheya, C Chapman, M Chibalina, H Dou, C Miranda, A González, ... Physiological reports 6 (17), e13852, 2018 | 100 | 2018 |
| Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes A Kim, JG Knudsen, JC Madara, A Benrick, TG Hill, LA Kadir, JA Kellard, ... Elife 10, e72919, 2021 | 27 | 2021 |
| Imaging Calcium Dynamics in Subpopulations of Mouse Pancreatic Islet Cells A Hamilton, E Vergari, C Miranda, AI Tarasov JoVE (Journal of Visualized Experiments), e59491, 2019 | 14 | 2019 |
| Gap junction coupling and islet delta-cell function in health and disease C Miranda, M Begum, E Vergari, LJB Briant Peptides 147, 170704, 2022 | 13 | 2022 |
| MCPH1 maintains long‐term epigenetic silencing of ANGPT2 in chronic lymphocytic leukemia PK Kopparapu, C Miranda, L Fogelstrand, K Mishra, PO Andersson, ... The FEBS journal 282 (10), 1939-1952, 2015 | 13 | 2015 |
| GLP-1 metabolite GLP-1 (9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion NR Gandasi, R Gao, L Kothegala, A Pearce, C Santos, S Acreman, ... Diabetologia 67 (3), 528-546, 2024 | 11 | 2024 |
| Somatostatin containing δ-cell number is reduced in type-2 diabetes L Kothegala, C Miranda, M Singh, JP Krieger, NR Gandasi International Journal of Molecular Sciences 24 (4), 3449, 2023 | 11 | 2023 |
| GLP-1 (9-36) mediates the glucagonostatic effect of GLP-1 by promiscuous activation of the glucagon receptor C Guida, C Miranda, IW Asterholm, D Basco, A Benrick, B Chanclon, ... bioRxiv, 785667, 2020 | 9 | 2020 |
| Lipophilicity predicts the ability of nonsulphonylurea drugs to block pancreatic beta‐cell KATP channels and stimulate insulin secretion; statins as a test case J Real, C Miranda, CS Olofsson, PA Smith Endocrinology, diabetes & metabolism 1 (2), e00017, 2018 | 7 | 2018 |
| Hindbrain insulin controls feeding behavior K Eerola, F Longo, TM Reinbothe, JE Richard, OT Shevchouk, ... Molecular Metabolism 66, 101614, 2022 | 6 | 2022 |
| AVP-induced counter-regulatory glucagon is diminished in type 1 diabetes A Kim, JG Knudsen, JC Madara, A Benrick, T Hill, LA Kadir, JA Kellard, ... BioRxiv, 2020 | 2 | 2020 |
| Promiscuous receptor activation mediates glucagonostatic effects of GLP-1 (9-36) and GLP-1 (7-36) C Guida, C Miranda, IW Asterholm, D Basco, A Benrick, B Chanclon, ... bioRxiv, 785667, 2019 | 2 | 2019 |
| Paracrine control of glucagon secretion in the pancreatic α-cell: Studies involving optogenetic cell activation C Miranda | | 2020 |
| 340-LB: Optogenetic Control of a-Cell Electrical Activity and Glucagon Secretion in Intact Islets CA MIRANDA, H DOU, J TOL, AI TARASOV, P RORSMAN Diabetes 68 (Supplement 1), 2019 | | 2019 |
| 339-LB: Modulation of Insulin and Glucagon Secretion by Optogenetic Control of Delta-Cell Electrical Activity in Pancreatic Islets H DOU, CA MIRANDA, Q ZHANG, P RORSMAN, J TOL Diabetes 68 (Supplement 1), 2019 | | 2019 |
| Inhibition of fatty acid synthase impairs insulin secretion in islets from mice fed both a normal and high-fat diet JI Real, C Miranda, SS Ahmadi, P Rorsman DIABETOLOGIA 60, S187-S187, 2017 | | 2017 |
| NADPH as a metabolic coupling factor: A player in glucagon secretion? C Miranda, SS Ahmadi, JI Real, P Rorsman DIABETOLOGIA 60, S241-S241, 2017 | | 2017 |
